BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26490357)

  • 1. A limited sampling strategy based on maximum a posteriori Bayesian estimation for a five-probe phenotyping cocktail.
    Nguyen TT; Bénech H; Pruvost A; Lenuzza N
    Eur J Clin Pharmacol; 2016 Jan; 72(1):39-51. PubMed ID: 26490357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
    Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
    Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling Method.
    Bosilkovska M; Samer C; Déglon J; Thomas A; Walder B; Desmeules J; Daali Y
    Basic Clin Pharmacol Toxicol; 2016 Sep; 119(3):284-90. PubMed ID: 27009433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design optimisation for pharmacokinetic modeling of a cocktail of phenotyping drugs.
    Nguyen TT; Bénech H; Delaforge M; Lenuzza N
    Pharm Stat; 2016; 15(2):165-77. PubMed ID: 26689604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of the Area under the Curve Using Limited-Point Blood Sampling in a Cocktail Study to Assess Multiple CYP Activities.
    Miura M; Tanaka S; Uchida S; Kamiya C; Katayama N; Hakamata A; Odagiri K; Inui N; Kawakami J; Watanabe H; Namiki N
    Biol Pharm Bull; 2021; 44(6):762-770. PubMed ID: 34078808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of tolbutamide, omeprazole, midazolam and dextromethorphan in human plasma by LC-MS/MS--a high throughput approach to evaluate drug-drug interactions.
    Zhang W; Han F; Guo P; Zhao H; Lin ZJ; Huang MQ; Bertelsen K; Weng N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(15-16):1169-77. PubMed ID: 20378422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic alterations in the Roux-en-Y gastric bypass recipients.
    Tandra S; Chalasani N; Jones DR; Mattar S; Hall SD; Vuppalanchi R
    Ann Surg; 2013 Aug; 258(2):262-9. PubMed ID: 23222033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex Phenotyping for Systems Medicine: A One-Point Optimized Practical Sampling Strategy for Simultaneous Estimation of CYP1A2, CYP2C9, CYP2C19, and CYP2D6 Activities Using a Cocktail Approach.
    de Andrés F; Terán S; Bovera M; Fariñas H; Terán E; LLerena A
    OMICS; 2016 Feb; 20(2):88-96. PubMed ID: 26600202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a six-probe cocktail (caffeine, tolbutamide, omeprazole, dextromethorphan, midazolam, and digoxin) approach to estimate hepatic drug detoxification capability and dosage requirements after a single oral dosing in healthy Chinese volunteers.
    Koo SH; Soon GH; Pruvost A; Benech H; Ang TL; Lee EJD; Ang DSW
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Jul; 395(7):815-826. PubMed ID: 35394133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous and comprehensive in vivo analysis of cytochrome P450 activity by using a cocktail approach in rats.
    Uchida S; Tanaka S; Namiki N
    Biopharm Drug Dispos; 2014 May; 35(4):228-36. PubMed ID: 24395703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocktail approach for in vivo phenotyping of 5 major CYP450 isoenzymes: development of an effective sampling, extraction, and analytical procedure and pilot study with comparative genotyping.
    Wohlfarth A; Naue J; Lutz-Bonengel S; Dresen S; Auwärter V
    J Clin Pharmacol; 2012 Aug; 52(8):1200-14. PubMed ID: 21885687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geneva cocktail for cytochrome p450 and P-glycoprotein activity assessment using dried blood spots.
    Bosilkovska M; Samer CF; Déglon J; Rebsamen M; Staub C; Dayer P; Walder B; Desmeules JA; Daali Y
    Clin Pharmacol Ther; 2014 Sep; 96(3):349-59. PubMed ID: 24722393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of the "Inje cocktail" for high-throughput evaluation of five human cytochrome P450 isoforms in vivo.
    Ryu JY; Song IS; Sunwoo YE; Shon JH; Liu KH; Cha IJ; Shin JG
    Clin Pharmacol Ther; 2007 Nov; 82(5):531-40. PubMed ID: 17392720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.
    Walzer M; Bekersky I; Blum RA; Tolbert D
    Pharmacotherapy; 2012 Apr; 32(4):340-53. PubMed ID: 22422635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of modafinil as a perpetrator of metabolic drug-drug interactions using a model informed cocktail reaction phenotyping trial protocol.
    Rowland A; van Dyk M; Warncken D; Mangoni AA; Sorich MJ; Rowland A
    Br J Clin Pharmacol; 2018 Mar; 84(3):501-509. PubMed ID: 29178272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lisdexamfetamine Dimesylate Effects on the Pharmacokinetics of Cytochrome P450 Substrates in Healthy Adults in an Open-Label, Randomized, Crossover Study.
    Ermer J; Corcoran M; Martin P
    Drugs R D; 2015 Jun; 15(2):175-85. PubMed ID: 25862215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the drug interaction potential of aplaviroc, a novel human immunodeficiency virus entry inhibitor, using a modified cooperstown 5 + 1 cocktail.
    Johnson BM; Song IH; Adkison KK; Borland J; Fang L; Lou Y; Berrey MM; Nafziger AN; Piscitelli SC; Bertino JS
    J Clin Pharmacol; 2006 May; 46(5):577-87. PubMed ID: 16638741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of felodipine as a potential perpetrator of pharmacokinetic drug-drug interactions.
    Snyder BD; Rowland A; Polasek TM; Miners JO; Doogue MP
    Eur J Clin Pharmacol; 2014 Sep; 70(9):1115-22. PubMed ID: 25028073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high-throughput assay using liquid chromatography-tandem mass spectrometry for simultaneous in vivo phenotyping of 5 major cytochrome p450 enzymes in patients.
    Ghassabian S; Chetty M; Tattam BN; Chem MC; Glen J; Rahme J; Stankovic Z; Ramzan I; Murray M; McLachlan AJ
    Ther Drug Monit; 2009 Apr; 31(2):239-46. PubMed ID: 19307938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous LC-MS/MS quantification of P-glycoprotein and cytochrome P450 probe substrates and their metabolites in DBS and plasma.
    Bosilkovska M; Déglon J; Samer C; Walder B; Desmeules J; Staub C; Daali Y
    Bioanalysis; 2014 Jan; 6(2):151-64. PubMed ID: 24423593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.